Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Alfasigma acquires IBS-C drug Zelnorm from Sloan Pharma Alfasigma acquisition of Zelnorm : Alfasigma USA, a subsidiary of Italian pharmaceutical company Alfasigma, has acquired IBS-C drug… bypharmanewsdailyJuly 8, 2019
